Literature DB >> 20553765

Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice.

Paulo Henrique Botton1, Marcelo S Costa, Ana Paula Ardais, Sabrina Mioranzza, Diogo O Souza, João Batista Teixeira da Rocha, Lisiane O Porciúncula.   

Abstract

Caffeine is a psychostimulant with positive effects on cognition. Recent studies have suggested the participation of the cholinergic system in the effects of caffeine on wakefulness. However, there are few studies assessing the contribution of cholinergic system in the cognitive enhancer properties of caffeine. In the present study, the effects of a dose and schedule of administration of caffeine that improved memory recognition were investigated on scopolamine-induced impairment of memory in adult mice. Inhibitory avoidance and novel object recognition tasks were used to assess learning and memory. Caffeine (10mg/kg, i.p.) was administered during 4 consecutive days, and the treatment was interrupted 24h before scopolamine administration (2mg/kg, i.p.). Scopolamine was administered prior to or immediately after training. Short-term and long-term memory was evaluated in both tasks. In the novel object recognition task, pre treatment with caffeine prevented the disruption of short- and long-term memory by scopolamine. In the inhibitory avoidance task, caffeine prevented short- but not long-term memory disruption by pre training administration of scopolamine. Caffeine prevented short- and long-term memory disruption by post training administration of scopolamine. Both treatments did not affect locomotor activity of the animals. These findings suggest that acute treatment with caffeine followed by its withdrawal may be effective against cholinergic-induced disruption of memory assessed in an aversive and non-aversive task. Finally, our results revealed that the cholinergic system is involved in the positive effects of caffeine on cognitive functions. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553765     DOI: 10.1016/j.bbr.2010.05.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  32 in total

1.  Altered behavior in experimental cortical dysplasia.

Authors:  Fu-Wen Zhou; Asha Rani; Hildabelis Martinez-Diaz; Thomas C Foster; Steven N Roper
Journal:  Epilepsia       Date:  2011-09-20       Impact factor: 5.864

Review 2.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

3.  Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.

Authors:  Sudhakar R Subramaniam; Iddo Magen; Nicholas Bove; Chunni Zhu; Vincent Lemesre; Garima Dutta; Chris Jean Elias; Henry A Lester; Marie-Francoise Chesselet
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

4.  Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.

Authors:  N Pagnussat; A S Almeida; D M Marques; F Nunes; G C Chenet; P H S Botton; S Mioranzza; C M Loss; R A Cunha; L O Porciúncula
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

5.  Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress.

Authors:  Kaiyue Sun; Yuting Bai; Rong Zhao; Zijiao Guo; Xiang Su; Peiqi Li; Pengyu Yang
Journal:  Metab Brain Dis       Date:  2018-11-07       Impact factor: 3.584

6.  Concentration- and age-dependent effects of chronic caffeine on contextual fear conditioning in C57BL/6J mice.

Authors:  Rachel L Poole; David Braak; Thomas J Gould
Journal:  Behav Brain Res       Date:  2015-03-28       Impact factor: 3.332

7.  Evaluation of Neuroprotective Effects of Quercetin against Aflatoxin B1-Intoxicated Mice.

Authors:  Enrico Gugliandolo; Alessio Filippo Peritore; Ramona D'Amico; Patrizia Licata; Rosalia Crupi
Journal:  Animals (Basel)       Date:  2020-05-21       Impact factor: 2.752

8.  Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.

Authors:  Ningjun Zhao; Xiaoying Zhuo; Yujiao Lu; Yan Dong; Mohammad Ejaz Ahmed; Donovan Tucker; Erin L Scott; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

9.  Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system.

Authors:  Mirna Ezzat Sorial; Nesrine Salah El Dine El Sayed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

10.  Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities.

Authors:  Patricia C Marisco; Fabiano B Carvalho; Michelle M Rosa; Bruna A Girardi; Jessié M Gutierres; Jeandre A S Jaques; Ana P S Salla; Víctor C Pimentel; Maria Rosa C Schetinger; Daniela B R Leal; Carlos F Mello; Maribel A Rubin
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.